Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes
Status:
Unknown status
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
Tuberculosis (TB) is a leading cause of death in HIV-infected individuals. There are
insufficient data correlating concentrations of anti-TB drugs with treatment response. We
hypothesize that sub-therapeutic concentrations of anti-TB drugs are associated with
inadequate TB treatment response to Mycobacterium tuberculosis.